179 related articles for article (PubMed ID: 26687605)
1. The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?
Covino DA; Sabbatucci M; Fantuzzi L
Curr Drug Targets; 2016; 17(1):76-110. PubMed ID: 26687605
[TBL] [Abstract][Full Text] [Related]
2. CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir.
Packard TA; Schwarzer R; Herzig E; Rao D; Luo X; Egedal JH; Hsiao F; Widera M; Hultquist JF; Grimmett ZW; Messer RJ; Krogan NJ; Deeks SG; Roan NR; Dittmer U; Hasenkrug KJ; Greene WC
mBio; 2022 Oct; 13(5):e0189122. PubMed ID: 36073812
[TBL] [Abstract][Full Text] [Related]
3. The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection.
Frade JM; Llorente M; Mellado M; Alcamí J; Gutiérrez-Ramos JC; Zaballos A; Real G; Martínez-A C
J Clin Invest; 1997 Aug; 100(3):497-502. PubMed ID: 9239395
[TBL] [Abstract][Full Text] [Related]
4. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation.
Sabbatucci M; Covino DA; Purificato C; Mallano A; Federico M; Lu J; Rinaldi AO; Pellegrini M; Bona R; Michelini Z; Cara A; Vella S; Gessani S; Andreotti M; Fantuzzi L
Retrovirology; 2015 Jan; 12():4. PubMed ID: 25608886
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis.
Williams DW; Calderon TM; Lopez L; Carvallo-Torres L; Gaskill PJ; Eugenin EA; Morgello S; Berman JW
PLoS One; 2013; 8(7):e69270. PubMed ID: 23922698
[TBL] [Abstract][Full Text] [Related]
6. Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease.
Santos FM; Costa VRdM; Araújo Sd; Sousa CDFd; Moreira TP; Gonçalves MR; Santos ACPMd; Ferreira HAS; Costa PAC; Barrioni BR; Bargi-Souza P; Pereira MdM; Nogueira ML; Souza DdG; Guimarães PPG; Teixeira MM; Queiroz-Junior CM; Costa VV
J Virol; 2024 Jan; 98(1):e0110223. PubMed ID: 38169294
[TBL] [Abstract][Full Text] [Related]
7. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.
Kadomoto S; Izumi K; Mizokami A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445235
[TBL] [Abstract][Full Text] [Related]
8. Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.
Fantuzzi L; Tagliamonte M; Gauzzi MC; Lopalco L
Cell Mol Life Sci; 2019 Dec; 76(24):4869-4886. PubMed ID: 31377844
[TBL] [Abstract][Full Text] [Related]
9. CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis.
Ansari AW; Heiken H; Meyer-Olson D; Schmidt RE
Eur J Immunol; 2011 Dec; 41(12):3412-8. PubMed ID: 22076814
[TBL] [Abstract][Full Text] [Related]
10. CCL2/CCR2-dependent recruitment of Th17 cells but not Tc17 cells to the lung in a murine asthma model.
Wang A; Wang Z; Cao Y; Cheng S; Chen H; Bunjhoo H; Xie J; Wang C; Xu Y; Xiong W
Int Arch Allergy Immunol; 2015; 166(1):52-62. PubMed ID: 25765592
[TBL] [Abstract][Full Text] [Related]
11. Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds.
Lança T; Costa MF; Gonçalves-Sousa N; Rei M; Grosso AR; Penido C; Silva-Santos B
J Immunol; 2013 Jun; 190(12):6673-80. PubMed ID: 23686489
[TBL] [Abstract][Full Text] [Related]
12. A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseases.
Rafei M; Galipeau J
Crit Rev Immunol; 2010; 30(5):449-61. PubMed ID: 21083526
[TBL] [Abstract][Full Text] [Related]
13. Dichotomous effects of C-C chemokines in HIV-1 pathogenesis.
Ansari AW; Heiken H; Moenkemeyer M; Schmidt RE
Immunol Lett; 2007 May; 110(1):1-5. PubMed ID: 17434211
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human cytomegalovirus replication by tricin is associated with depressed CCL2 expression.
Akai Y; Sadanari H; Takemoto M; Uchide N; Daikoku T; Mukaida N; Murayama T
Antiviral Res; 2017 Dec; 148():15-19. PubMed ID: 28965916
[TBL] [Abstract][Full Text] [Related]
15. CCL2/CCR2 signaling in cancer pathogenesis.
Hao Q; Vadgama JV; Wang P
Cell Commun Signal; 2020 May; 18(1):82. PubMed ID: 32471499
[TBL] [Abstract][Full Text] [Related]
16. The innate immune response to lower respiratory tract E. Coli infection and the role of the CCL2-CCR2 axis in neonatal mice.
McGrath-Morrow SA; Ndeh R; Collaco JM; Poupore AK; Dikeman D; Zhong Q; Singer BD; D'Alessio F; Scott A
Cytokine; 2017 Sep; 97():108-116. PubMed ID: 28628889
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus replication supported by virus-induced activation of CCL2-CCR2 interactions.
Murayama T; Kikuchi M; Miita T; Yamada R; Matsubara K; Sadanari H; Mukaida N
Biochem Biophys Res Commun; 2014 Oct; 453(3):321-5. PubMed ID: 25261725
[TBL] [Abstract][Full Text] [Related]
18. Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals.
Ansari AW; Bhatnagar N; Dittrich-Breiholz O; Kracht M; Schmidt RE; Heiken H
Int Immunol; 2006 Oct; 18(10):1443-51. PubMed ID: 16916890
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the chemokine and chemokine receptors: impact on clinical course and therapy of the human immunodeficiency virus type 1 infection (HIV-1).
Reiche EM; Bonametti AM; Voltarelli JC; Morimoto HK; Watanabe MA
Curr Med Chem; 2007; 14(12):1325-34. PubMed ID: 17504215
[TBL] [Abstract][Full Text] [Related]
20. CCL2, but not its receptor, is essential to restrict immune privileged central nervous system-invasion of Japanese encephalitis virus via regulating accumulation of CD11b(+) Ly-6C(hi) monocytes.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Kim K; Eo SK
Immunology; 2016 Oct; 149(2):186-203. PubMed ID: 27260136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
